KIT expression and methylation in medulloblastoma and PNET cell lines and tumors.
about
Potential approaches to the treatment of Ewing's sarcomaA contemporary review of molecular candidates for the development and treatment of childhood medulloblastoma.Angiogenesis and angiogenic tyrosine kinase receptor expression in pediatric brain tumors.The FDA approved PI3K inhibitor GDC-0941 enhances in vitro the anti-neoplastic efficacy of Axitinib against c-myc-amplified high-risk medulloblastoma.
P2860
KIT expression and methylation in medulloblastoma and PNET cell lines and tumors.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
KIT expression and methylation in medulloblastoma and PNET cell lines and tumors.
@en
KIT expression and methylation in medulloblastoma and PNET cell lines and tumors.
@nl
type
label
KIT expression and methylation in medulloblastoma and PNET cell lines and tumors.
@en
KIT expression and methylation in medulloblastoma and PNET cell lines and tumors.
@nl
prefLabel
KIT expression and methylation in medulloblastoma and PNET cell lines and tumors.
@en
KIT expression and methylation in medulloblastoma and PNET cell lines and tumors.
@nl
P2093
P2860
P1476
KIT expression and methylation in medulloblastoma and PNET cell lines and tumors
@en
P2093
Callie G Flack
Caroline E Talsma
Jason A Heth
Jessica G Crowley
Juan A Rey
Karin M Muraszko
Lisa L Hamm
Mark A Costello
Mikel Gurrea
Mónica Enguita-Germán
P2860
P2888
P304
P356
10.1007/S11060-010-0391-6
P577
2010-09-19T00:00:00Z